Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database

BACKGROUND: Although the role of adjuvant chemotherapy (CT) for resectable biliary tract cancer (BTC) is gradually recognized, the benefit of adjuvant chemoradiotherapy (CRT) is still controversial. Our study is designed to compare the prognosis of CRT versus CT in BCT patients. METHODS: Clinicopath...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yueting, Liu, Xia, Lin, Yiyun, Tang, Liansha, Yi, Xianyanling, Xu, Hang, Yuan, Yunlong, Chen, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472568/
https://www.ncbi.nlm.nih.gov/pubmed/37658421
http://dx.doi.org/10.1186/s40001-023-01299-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472568/
https://www.ncbi.nlm.nih.gov/pubmed/37658421
http://dx.doi.org/10.1186/s40001-023-01299-w

Ejemplares similares